Age at Diagnosis and ER Status
. | <50 y . | . | ≥50 y . | . | ||||
---|---|---|---|---|---|---|---|---|
A. Patients with known ER status (n = 451) | ||||||||
ER− | 21 | 41 | 62 | |||||
ER+ | 79 | 310 | 389 | |||||
100 | 351 | 451 | χ2 P = 0.017 | |||||
B. Patients carrying the CYP1A2*1F A/A genotype (n = 230) | ||||||||
ER− | 6 | 23 | 29 | |||||
ER+ | 48 | 153 | 201 | |||||
54 | 176 | 230 | χ2 P = 0.70 | |||||
C. Patients carrying at least one CYP1A2*1F C allele (n = 221) | ||||||||
ER− | 15 | 18 | 33 | |||||
ER+ | 31 | 157 | 188 | |||||
46 | 175 | 221 | χ2 P = 0.0002 |
. | <50 y . | . | ≥50 y . | . | ||||
---|---|---|---|---|---|---|---|---|
A. Patients with known ER status (n = 451) | ||||||||
ER− | 21 | 41 | 62 | |||||
ER+ | 79 | 310 | 389 | |||||
100 | 351 | 451 | χ2 P = 0.017 | |||||
B. Patients carrying the CYP1A2*1F A/A genotype (n = 230) | ||||||||
ER− | 6 | 23 | 29 | |||||
ER+ | 48 | 153 | 201 | |||||
54 | 176 | 230 | χ2 P = 0.70 | |||||
C. Patients carrying at least one CYP1A2*1F C allele (n = 221) | ||||||||
ER− | 15 | 18 | 33 | |||||
ER+ | 31 | 157 | 188 | |||||
46 | 175 | 221 | χ2 P = 0.0002 |